Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Providers
Hospitals
Practices
Retail
Health Tech
AI and Machine Learning
Digital Health
Telehealth
Finance
Payers
Regulatory
Special Reports
Podcasts
Resources
Webinars
Fierce Events
Industry Events
Podcasts
Whitepapers
Subscribe
What are you searching for?
Enclose phrases in quotes. Use a + to require a term in results and - to exclude terms.
Example: +water -Europe
Subscribe
Providers
Hospitals
Practices
Retail
Health Tech
AI and Machine Learning
Digital Health
Telehealth
Finance
Payers
Regulatory
Special Reports
Podcasts
Resources
Webinars
Fierce Events
Industry Events
Podcasts
Whitepapers
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Genomics
Health Tech
Why data is 23andMe's 'secret power' for drug development
Using genetic data based on the company's 12 million genotype customers gives 23andMe a distinct advantage in drug development, Kenneth Hillan says.
Heather Landi
Jan 20, 2022 5:00pm
Color reaches $4.6B valuation after latest funding round
Nov 9, 2021 3:40pm
Livongo alum launches FemTech Health with $38M in investor cash
Nov 3, 2021 12:30pm
23andMe shells out $400M for telehealth provider Lemonaid Health
Oct 22, 2021 10:05am
NIH Director Collins to step down before end of year
Oct 5, 2021 11:04am
Invitae scoops up consumer health tech firm Ciitizen for $325M
Sep 8, 2021 7:45am